Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia

Melanoma and Skin Cancer

Declining invasive and rising in situ melanoma incidence trends in Iceland: A nationwide cohort study

J Eur Acad Dermatol Venereol

Thomas S, Hoyt D, Stoddard G, Snyder AM, Andradottir E, Grant-Kels JM, Ungar J, Lewin JM, Gulati N, Jonasson JG, Sigurdsson H, Helgadottir H, Adalsteinsson JA

doi: 10.1111/jdv.20386

Melanoma and Skin Cancer

Risk of Death Due to Melanoma and Other Causes in Patients With Thin Cutaneous Melanomas

JAMA Dermatol

Lo SN, Williams GJ, Cust AE, Ollila DW, Varey AHR, Ch'ng S, Scolyer RA, Thompson JF

doi: 10.1001/jamadermatol.2024.4900

Melanoma and Skin Cancer

Psychosocial wellbeing in people with melanoma in-situ: a systematic review

Melanoma Res

Zheng L, Susanto AK, Soyer HP, Janda M, Catapan SC

doi: 10.1097/CMR.0000000000001007

Melanoma and Skin Cancer

Long-term outcomes and patterns of recurrence in patients with thin melanoma and a negative sentinel lymph node biopsy: a single-center experience

Melanoma Res

Shemer M, Shimonovitz M, Furer R, Abu-Abeid A, Dayan D, Schneebaum S, Miodovnik M, Nizri E

doi: 10.1097/CMR.0000000000000986

Melanoma and Skin Cancer

Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort

Melanoma Res

Macaire C, Lefevre W, Dalac S, Montaudié H, Legoupil D, Dereure O, Dutriaux C, Leccia MT, Aubin F, Grob JJ, Saiag P, De Quatrebarbes J, Maubec E, Lesimple T, Granel-Brocard F, Mortier L, Dalle S, Lebbé C, Prod'homme C

doi: 10.1097/CMR.0000000000000973

Melanoma and Skin Cancer

Mohs micrographic surgery for the treatment of invasive melanoma: A systematic review with meta-analyses

J Eur Acad Dermatol Venereol

Williams GJ, Quinn T, Lo S, Guitera P, Scolyer RA, Thompson JF, Ch'ng S

doi: 10.1111/jdv.20138

Melanoma and Skin Cancer

Tumor Upstaging in Invasive Melanoma is Associated with Changes in Clinical Management and Worse Prognosis

J Am Acad Dermatol

Rosenthal A, Kim JY, Juhasz ML, Conde G, Chen C, Eng S, Carrasco Mendoza CA, Chang CT, Ticknor I, Doan L, Schwarzmann KB, Garzione S, Li Y, Islas ZA, Gharavi NM, Man JR

doi: 10.1016/j.jaad.2024.11.028

Melanoma and Skin Cancer

Trends in Invasive Melanoma Thickness in Norway, 1983-2019

Acta Derm Venereol

Rimal R, Robsahm TE, Green AC, Ghiasvand R, Rueegg CS, Bassarova A, Gjersvik P, Weiderpass E, Aalen OO, Møller B, Perrier F, Veierød MB

doi: 10.2340/actadv.v104.26110

Psoriatic Arthritis

Adherence, Persistence, Healthcare Resource Use, and Costs in Tofacitinib-Treated Patients with Psoriatic Arthritis: Data from Two United States Claims Databases

Adv Ther

Mease PJ, Papademetriou E, Potluri R, Agarwal E, Cappelleri JC, Ling YL

doi: 10.1007/s12325-024-02904-y

Related content

Declining invasive and rising in situ melanoma incidence trends in Iceland: A nationwide cohort study

Risk of Death Due to Melanoma and Other Causes in Patients With Thin Cutaneous Melanomas

Psychosocial wellbeing in people with melanoma in-situ: a systematic review

Long-term outcomes and patterns of recurrence in patients with thin melanoma and a negative sentinel lymph node biopsy: a single-center experience

Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort

Mohs micrographic surgery for the treatment of invasive melanoma: A systematic review with meta-analyses

Tumor Upstaging in Invasive Melanoma is Associated with Changes in Clinical Management and Worse Prognosis

Trends in Invasive Melanoma Thickness in Norway, 1983-2019

Adherence, Persistence, Healthcare Resource Use, and Costs in Tofacitinib-Treated Patients with Psoriatic Arthritis: Data from Two United States Claims Databases